cbdMD, Inc. (YCBD) stock
YCBDNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/3081% below fair value
$0.36+0.00 (+0.28%)
Close on Nov 17, 2026Market cap $4.08MP/E –Yield –
cbdMD operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
cbdMD's operating cash flow for the twelve months ending Jun 30, 2026 was -$2.22M. For fiscal 2025 it was -$1.45M. The highest annual figure on record is -$352.79K in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$1.45M | – |
| FY2024 | Sep 30, 2024 | -$352.79K | – |
| FY2023 | Sep 30, 2023 | -$4.30M | – |
| FY2022 | Sep 30, 2022 | -$14.97M | – |
| FY2021 | Sep 30, 2021 | -$14.09M | – |
| FY2020 | Sep 30, 2020 | -$10.66M | – |
| FY2019 | Sep 30, 2019 | -$15.38M | – |
| FY2018 | Sep 30, 2018 | -$5.57M | – |
| FY2017 | Sep 30, 2017 | -$2.33M | – |
| FY2016 | Sep 30, 2016 | -$2.90M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | -$442.16K | – |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | -$722.50K | – |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | -$812.46K | – |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | -$240.75K | -243.8% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | -$704.20K | -343.0% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | -$189.48K | – |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | -$317.95K | – |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $167.38K | – |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $289.78K | – |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | -$704.07K | – |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | -$105.88K | – |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | -$263.50K | – |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | -$240.57K | – |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | -$1.73M | – |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | -$2.06M | – |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | -$1.93M | – |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | -$2.37M | – |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | -$4.33M | – |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | -$4.61M | – |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | -$2.96M | – |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | -$2.19M | – |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | -$387.25K | – |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | -$1.13M | – |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | -$4.27M | – |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | -$4.87M | – |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | -$6.32M | – |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | -$4.59M | – |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | -$3.30M | – |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | -$1.16M | – |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | -$732.73K | – |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | -$1.29M | – |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | -$1.73M | – |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | -$1.82M | – |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | -$912.49K | – |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | -$133.68K | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | -$755.03K | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | -$528.64K | – |
See a number that looks wrong?